Middle East & Africa Bioanalytical Testing Services Market Forecast to 2030
Middle East & Africa Bioanalytical Testing Services Market Forecast to 2030 – Regional Analysis – by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Drug Discovery and Development Activities for Emerging and Rare Diseases Fuel the Middle East & Africa Bioanalytical Testing Services Market
Bioanalytical testing services are used for the quantitative estimation of drugs and their metabolites in biological fluids. This testing is performed in the early stages of the drug development. Various biotechnology companies are engaging in collaborations to accelerate R&D activities and scale them up on a global level. Several ongoing drug research studies have shown positive outcomes for effectively treating chronic disorders such as cancer, neurological disorders, and autoimmune disorders. An upsurge in the prevalence of such disorders, coupled with the increase in R&D activities, would create demand for bioanalytical testing services in the coming years. An increase in the incidence of rare disorders such as amyloidosis, adrenoleukodystrophy, and Ehlers-Danlos syndrome has further bolstered the R&D activities for the development of interventions against them, which has been generating the demand for specific bioanalytical testing services. According to the Food and Drug Administration (FDA), in 2022, the Center for Drug Evaluation and Research (CDER) approved 37 novel drugs. Out of 37, 20 drugs were approved for rare diseases. Thus, the continuous efforts of drug companies to discover and develop drugs against rare and emerging diseases are expected to provide lucrative opportunities for the expansion of the bioanalytical testing service businesses during the forecast period.
Middle East & Africa Bioanalytical Testing Services Market Overview
The Middle East & Africa bioanalytical testing services market is segmented into UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Government initiatives to strengthen analytical testing capacities and growing number of drug approvals and clinical trials are catalyzing the bioanalytical testing services market in the Middle East & Africa. The increasing use and development of numerous macromolecules and biosimilars for various therapeutic areas and increased government spending to set up new laboratories are other factors accelerating the bioanalytical testing services market growth.
Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Bioanalytical Testing Services Market Segmentation
The Middle East & Africa bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.
Based on test type, the Middle East & Africa bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.
Based on disease indication, the Middle East & Africa bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.
Based on end user, the Middle East & Africa bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.
Based on country, the Middle East & Africa bioanalytical testing services market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa bioanalytical testing services market share in 2022.
SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the Middle East & Africa bioanalytical testing services market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to The Research Team’ research, the Middle East & Africa bioanalytical testing services market was valued at US$ 221.87 million in 2022 and is expected to reach US$ 435.80 million by 2030, registering a CAGR of 8.8% from 2022 to 2030. Increasing outsourcing of R&D activities by pharmaceutical companies and high demand for analytical testing of biosimilars and biologics are the critical factors attributed to the Middle East & Africa bioanalytical testing services market expansion.
Pharmaceutical companies outsource research & development activities that are not core to their internal structure. Outsourcing miscellaneous activities allows them to efficiently focus on their internal core competencies for making the drug development process better and more cost effective. Moreover, outsourcing manufacturing activities, along with R&D, benefits them by lowering the turnaround period, adding to their expertise, and eliminating the need for large capital investments. Pharmaceutical businesses are widely implementing the quality-by-design (QbD) concept, which is further propelling the adoption of outsourcing services by pharmaceutical companies to increase the robustness of their production processes and ensure optimal product quality and manufacturing productivity. The concept has gained traction in the pharmaceutical industry over the years with the publication of ICH Q9 (Quality Risk Management), ICH Q8 (R2, Pharmaceutical Development), and ICH Q10 (Pharmaceutical Quality System). According to the ICH Q10 guidelines, analytical methods are essential to the pharmaceutical quality system. Analytical QbD (AQbD) implementation in manufacturing ensures product quality and performance. Outsourcing bioanalytical testing services helps pharmaceutical businesses reduce business risks by avoiding major investments in analytical equipment and skilled professionals, especially while the product is in the early phase of development. Due to the availability of specialized analytical testing service providers with crucial competencies to quickly provide excellent results, pharmaceutical companies are increasingly considering outsourcing bioanalytical testing services to third-party service providers, which fuels the market growth.
On the contrary, high cost associated to bioanalytical testing services hurdles the growth of Middle East & Africa bioanalytical testing services market.
Based on test type, the Middle East & Africa bioanalytical testing services market is categorized into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held 24.3% market share in 2022, amassing US$ 53.88 million. It is projected to garner US$ 114.75 million by 2030 to expand at 9.9% CAGR during 2022-2030.
Based on disease indication, the Middle East & Africa bioanalytical testing services market is categorized into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held 22.6% market share in 2022, amassing US$ 50.07 million. It is projected to garner US$ 106.22 million by 2030 to expand at 9.9% CAGR during 2022-2030.
Based on end user, the Middle East & Africa bioanalytical testing services market is categorized into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held 61.8% share of Middle East & Africa bioanalytical testing services market in 2022, amassing US$ 137.19 million. It is projected to garner US$ 279.89 million by 2030 to expand at 9.3% CAGR during 2022-2030.
Based on country, the Middle East & Africa bioanalytical testing services market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 40.1% share of Middle East & Africa bioanalytical testing services market in 2022. It was assessed at US$ 89.00 million in 2022 and is likely to hit US$ 172.20 million by 2030, exhibiting a CAGR of 8.6% during 2022-2030.
Key players operating in the Middle East & Africa bioanalytical testing services market are SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, and Biomarker Services LLC, ICON Plc, and Intertek Group Plc, among others.
In July 2022, Eurofins acquired WESSLING Hungary enhancing its environmental, food and BioPharma product testing offering.
In Jan 2023, Charles River and Rznomics Announced the RNA-based Anticancer Gene Therapy Manufacturing Alliance.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioanalytical testing services market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioanalytical testing services market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioanalytical testing services market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioanalytical Testing Services Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
5. Middle East & Africa Bioanalytical Testing Services Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
5.2 Key Market Restraints:
5.2.1 High Cost Associated to Bioanalytical Testing Services
5.3 Key Market Opportunities
5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
5.4 Future Trends
5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
5.5 Impact Analysis:
6. Bioanalytical Testing Services Market – Middle East & Africa Market Analysis
6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 – 2030
7. Middle East & Africa Bioanalytical Testing Services Market – Revenue and Forecast to 2030 – by Services
7.1 Overview
7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
7.3 Pharmacokinetics
7.3.1 Overview
7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Biomarkers
7.4.1 Overview
7.4.2 Biomarkers: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Immunogenicity
7.5.1 Overview
7.5.2 Immunogenicity: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Virology Testing
7.6.1 Overview
7.6.2 Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 In-Vitro Virology Testing
7.6.2.1.1 Overview
7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.6.3 In-Vivo Virology Testing
7.6.3.1 Overview
7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Cell-Based Assays
7.7.1 Overview
7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Bioanalytical Testing Services Market – Revenue and Forecast to 2030 – by Disease Indication
8.1 Overview
8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
8.3 Cardiovascular
8.3.1 Overview
8.3.2 Cardiovascular: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Neurological Diseases
8.4.1 Overview
8.4.2 Neurological Diseases: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Autoimmune Disorders
8.5.1 Overview
8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Respiratory Diseases
8.6.1 Overview
8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Metabolic Disorders
8.7.1 Overview
8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Oncology
8.8.1 Overview
8.8.2 Oncology: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Sexual Health
8.9.1 Overview
8.9.2 Sexual Health: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Bone Disease
8.10.1 Overview
8.10.2 Bone Disease: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.11 Others
8.11.1 Overview
8.11.2 Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Bioanalytical Testing Services Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Pharmaceutical and Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organization (CRO)
9.4.1 Overview
9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Development And Manufacturing Organization (CDMO)
9.5.1 Overview
9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Bioanalytical Testing Services Market – Country Analysis
10.1 Middle East & Africa Bioanalytical Testing Services Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.1.1 Middle East & Africa Bioanalytical Testing Services Market by Country
10.1.1.2 UAE
10.1.1.2.1 Overview
10.1.1.2.2 UAE Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 UAE Bioanalytical Testing Services Market, by Services
10.1.1.2.3.1 UAE Bioanalytical Testing Services Market, by Virology Testing
10.1.1.2.4 UAE Bioanalytical Testing Services Market, by Disease Indication
10.1.1.2.5 UAE Bioanalytical Testing Services Market, by End User
10.1.1.3 Saudi Arabia
10.1.1.3.1 Overview
10.1.1.3.2 Saudi Arabia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Saudi Arabia Bioanalytical Testing Services Market, by Services
10.1.1.3.3.1 Saudi Arabia Bioanalytical Testing Services Market, by Virology Testing
10.1.1.3.4 Saudi Arabia Bioanalytical Testing Services Market, by Disease Indication
10.1.1.3.5 Saudi Arabia Bioanalytical Testing Services Market, by End User
10.1.1.4 South Africa
10.1.1.4.1 Overview
10.1.1.4.2 South Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 South Africa Bioanalytical Testing Services Market, by Services
10.1.1.4.3.1 South Africa Bioanalytical Testing Services Market, by Virology Testing
10.1.1.4.4 South Africa Bioanalytical Testing Services Market, by Disease Indication
10.1.1.4.5 South Africa Bioanalytical Testing Services Market, by End User
10.1.1.5 Rest of Middle East & Africa
10.1.1.5.1 Overview
10.1.1.5.2 Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Services
10.1.1.5.3.1 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Virology Testing
10.1.1.5.4 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Disease Indication
10.1.1.5.5 Rest of Middle East & Africa Bioanalytical Testing Services Market, by End User
11. Bioanalytical Testing Services Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioanalytical Testing Services Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 SGS SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pharmaron Beijing Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Element Materials Technology Group Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eurofins Scientific SE
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Labcorp Drug Development Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Syneos Health Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ICON Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Intertek Group Plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Bioanalytical Testing Services Market Segmentation
Table 2. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 3. UAE Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) – Virology Testing
Table 4. UAE Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) – Disease Indication
Table 5. UAE Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 6. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 7. Saudi Arabia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) – Virology Testing
Table 8. Saudi Arabia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) – Disease Indication
Table 9. Saudi Arabia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 10. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 11. South Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) – Virology Testing
Table 12. South Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) – Disease Indication
Table 13. South Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 14. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 15. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 16. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 17. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 18. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
Table 19. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
Table 20. Glossary of Terms, Middle East & Africa Bioanalytical Testing Services Market
LIST OF FIGURES
Figure 1. Middle East & Africa Bioanalytical Testing Services Market Segmentation, By Country
Figure 2. Middle East & Africa – PEST Analysis
Figure 3. Middle East & Africa Bioanalytical Testing Services Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Middle East & Africa Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Biomarkers: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Immunogenicity: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Middle East & Africa Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 16. Cardiovascular: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Neurological Diseases: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 1. Autoimmune Disorders: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 2. Respiratory Diseases: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 3. Metabolic Disorders: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 4. Oncology: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 5. Sexual Health: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Bone Disease: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Middle East & Africa Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
Figure 9. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Contract Research Organization (CRO): Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Middle East & Africa Bioanalytical Testing Services Market, by Country, 2022 ($ Million)
Figure 14. Middle East & Africa Bioanalytical Testing Services Market, By Key Countries, 2022 and 2030 (%)
Figure 15. UAE Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
Figure 16. Saudi Arabia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
Figure 17. South Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
Figure 18. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
Figure 19. Growth Strategies in the Bioanalytical Testing Services Market
The List of Companies – Middle East & Africa Bioanalytical Testing Services Market
1. SGS SA
2. Pharmaron Beijing Co Ltd
3. Element Materials Technology Group Ltd
4. Charles River Laboratories International Inc
5. Eurofins Scientific SE
6. Labcorp Drug Development Inc
7. Syneos Health Inc
8. ICON Plc
9. Intertek Group Plc
You must be logged in to post a review.
Reviews
There are no reviews yet.